Made Scientific Selected for Columbia’s NOVAKnee Program
PRINCETON, N.J., June 1, 2026 Made Scientific has been selected as the manufacturing partner for Columbia University’s NOVAKnee program,...
Stem Cell Therapy
Advertisement
TreeFrog’s TFG-001 Shows Strong Parkinson’s Recovery Data
BORDEAUX, France, May 25, 2026 TreeFrog Therapeutics announced new preclinical data showing that its investigational 3D neural microtissue cell...
Longeveron Reports Constructive FDA Meeting Ahead of ELPIS II HLHS Data Readout
MIAMI, Florida, United States – May 10, 2026 Longeveron announced details from a constructive Type C meeting with the...
Caris Life Sciences Unveils AI Test for Breast Cancer Recurrence
IRVING, Texas, May 5, 2026 Caris Life Sciences has announced the launch of Caris MI Clarity™, an advanced AI-powered...
Gallant Advances Stem Cell Therapy for Canine OA
SAN DIEGO, May 6, 2026 Gallant, an emerging animal health biotechnology company focused on regenerative veterinary medicine, has announced...
Advertisements
XellSmart Advances Phase 2 Parkinson’s Cell Therapy Trial
Suzhou, China | April 14, 2026 XellSmart has announced the initiation of a multicenter Phase II clinical trial evaluating...
MEDIPOST Secures Japan Commercial Deal for CARTISTEM® Therapy
Seoul, South Korea, December 19, 2025 — MEDIPOST Co., Ltd., a fully integrated cell therapy biotechnology company, has entered...
Omisirge Delivers Breakthrough Outcomes for Severe Aplastic Anemia
DUBLIN, IRELAND & LONDON, UK — December 8, 2025 — Ayrmid Ltd., parent company of Gamida Cell Inc., announced...
HEMOSTEMIX EXPANDS CLINICAL OPERATIONS WITH NEW PATIENT-CARE DIRECTOR
CALGARY, Alberta — December 4, 2025 — Hemostemix Inc., a leader in autologous stem-cell therapeutics, has appointed Shaune Harding,...
Hemostemix Expands With First Cardiology Practice Acquisitions
CALGARY, Alberta — November 26, 2025. Hemostemix Inc. has taken a major step in its global clinical-commercial expansion, announcing...
Advertisement
